This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. slipped 5.5% to $7.87 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.6% to 18,350.19 and Dow Jones Industrial Average falling 1.5% to 43,191.24.
Novavax Inc. closed 67.0% below its 52-week high of $23.86, which the company reached on June 6th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 1.4% to $167.28, Pfizer Inc. fell 0.7% to $26.25, and Merck & Co. Inc. rose 0.98% to $93.15.
Trading volume totaled 6.1 million, compared to the 50-day average of 4.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 03, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。